Turquoise Health Raises $40M in Series C to Expand Healthcare Pricing Platform
Somewhere between a hospital bill and a payer contract, there is a black hole where logic goes to die and spreadsheets go to multiply. That gap has been printing confusion for years. Chris Severn saw it up close, not from a boardroom but from the trenches where reimbursement models get messy and margins get thinner. So Chris Severn and Adam Geitgey built Turquoise Health to do something radical in healthcare. Make the numbers make sense, and make them move.
Turquoise Health just pulled in $40M in Series C funding, led by Oak HC/FT with Andreessen Horowitz, Adams Street Partners, and Yosemite doubling down. That is not casual capital showing up for a cameo. That is conviction with patience. Vig Chandramouli and team are betting on infrastructure over optics, and that distinction matters when the problem you are attacking burns nearly $1T a year in administrative drag.
Let’s talk scale, because this is where theory clocks out and reality steps in. More than 280 customers are already plugged in. 10 of the top 25 health systems. 4 of 5 national payers. 9 of the top 10 pharmaceutical companies. 6 of the top 10 insurance brokers. That is not a pipeline story. That is presence. That is distribution with teeth.
The product stack reads like a quiet takeover in motion. Clear Rates pulls chaos into a single, auditable price. Contracts turns dense legal language into something you can actually interrogate without a law degree and a headache. AskTQ compresses weeks of digging into seconds of answers. Together, they form Transaction Efficiency, which sounds polite until you realize it is dismantling fragmented workflows and calling it progress.
Nearly 200 people built this in 5 years. That kind of velocity does not come from hype cycles or polished decks. It comes from timing, access to newly exposed pricing data, and a team that understood exactly where inefficiencies were hiding. Regulation opened the door, but Turquoise Health walked in with a blueprint and stayed to build.
Amy Golding, Marcus Dorstel, and Jenn Misora are translating that blueprint into execution across revenue, operations, and culture. Because product might start the conversation, but trust and consistency close it.
The lesson sitting underneath all of this is not subtle. When data becomes accessible, the winners are the ones who make it usable, actionable, and impossible to ignore. Turquoise Health did not just interpret the moment. They structured it, packaged it, and turned it into leverage.
